OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Dynamic Contrast-Enhanced MRI data can be quantified to produce reproducible measurements of tissue perfusion, permeability, vascularity and cellularity at high spatial resolution (~1mm). Numerous studies have demonstrated a potential utility of these parameters for non-invasive tumour characterisation, prediction or monitoring of treatment response, or for optimisation of various treatments including radiotherapy or anti-angiogenic treatment. On the other hand, one has to observe that despite this large body of evidence the role of DCE-MRI in daily clinical practice or clinical trials remains limited.
In this talk I will aim to identify the causes for this gap between scientific evidence and clinical application, propose strategies to close the gap in the future, and present current research plans of our group in Leeds. I will also briefly review the basic principles and terminology of DCE-MRI as this is needed to make sense of the multitude of different approaches in the literature.
